CuS nanodots with ultrahigh efficient renal clearance for positron emission tomography imaging and image-guided photothermal therapy M Zhou, J Li, S Liang, AK Sood, D Liang, C Li ACS nano 9 (7), 7085-7096, 2015 | 315 | 2015 |
Toward highly potent cancer agents by modulating the C-2 group of the arylthioindole class of tubulin polymerization inhibitors G La Regina, R Bai, WM Rensen, E Di Cesare, A Coluccia, F Piscitelli, ... Journal of medicinal chemistry 56 (1), 123-149, 2013 | 108 | 2013 |
A dual-targeting anticancer approach: soil and seed principle J Li, Z Sun, J Zhang, H Shao, M Miranda Cona, H Wang, T Marysael, ... Radiology 260 (3), 799-807, 2011 | 94 | 2011 |
A review on various targeted anticancer therapies J Li, F Chen, MM Cona, Y Feng, U Himmelreich, R Oyen, A Verbruggen, ... Targeted oncology 7, 69-85, 2012 | 93 | 2012 |
Research perspectives: gold nanoparticles in cancer theranostics J Li, S Gupta, C Li Quantitative Imaging in Medicine and Surgery 3 (6), 284-291, 2013 | 71 | 2013 |
Morphological, functional and metabolic imaging biomarkers: assessment of vascular-disrupting effect on rodent liver tumours H Wang, J Li, F Chen, F De Keyzer, J Yu, Y Feng, J Nuyts, G Marchal, Y Ni European radiology 20, 2013-2026, 2010 | 58 | 2010 |
Diffusion‐weighted MRI of hepatic tumor in rats: Comparison between in vivo and postmortem imaging acquisitions X Sun, H Wang, F Chen, F De Keyzer, J Yu, Y Jiang, Y Feng, J Li, ... Journal of Magnetic Resonance Imaging: An Official Journal of the …, 2009 | 54 | 2009 |
Exploring theranostic potentials of radioiodinated hypericin in rodent necrosis models J Li, MM Cona, F Chen, Y Feng, L Zhou, J Yu, J Nuyts, P de Witte, J Zhang, ... Theranostics 2 (10), 1010-1019, 2012 | 53 | 2012 |
Sequential Systemic Administrations of Combretastatin A4 Phosphate and Radioiodinated Hypericin Exert Synergistic Targeted Theranostic Effects with Prolonged Survival on SCID … J Li, MM Cona, F Chen, Y Feng, L Zhou, G Zhang, J Nuyts, P de Witte, ... Theranostics 3 (2), 127-137, 2013 | 50 | 2013 |
Radiolabeled iodohypericin as tumor necrosis avid tracer: diagnostic and therapeutic potential M Van de Putte, T Marysael, H Fonge, T Roskams, MM Cona, J Li, ... International Journal of Cancer 131 (2), E129-E137, 2012 | 48 | 2012 |
Tumor models and specific contrast agents for small animal imaging in oncology Y Ni, H Wang, F Chen, J Li, F DeKeyzer, Y Feng, J Yu, H Bosmans, ... Methods 48 (2), 125-138, 2009 | 43 | 2009 |
Interventional Nanotheranostics of Pancreatic Ductal Adenocarcinoma J Li, F Liu, S Gupta, C Li Theranostics, 2016 | 40 | 2016 |
Hepatocellular Carcinoma: Intraarterial Delivery of Doxorubicin loaded Hollow Gold Nanospheres for Photothermal Ablation— Chemoembolization Therapy in Rats J Li, M Zhou, F Liu, C Xiong, W Wang, Q Cao, X Wen, D Robertson, X Ji, ... Radiology, 2016 | 36 | 2016 |
Rat model of reperfused partial liver infarction: characterization with multiparametric magnetic resonance imaging, microangiography, and histomorphology X Wu, H Wang, F Chen, L Jin, J Li, Y Feng, F DeKeyzer, J Yu, G Marchal, ... Acta radiologica 50 (3), 276-287, 2009 | 35 | 2009 |
Development and evaluation of a 68Ga labeled pamoic acid derivative for in vivo visualization of necrosis using positron emission tomography K Prinsen, J Li, H Vanbilloen, P Vermaelen, E Devos, L Mortelmans, ... Bioorganic & medicinal chemistry 18 (14), 5274-5281, 2010 | 33 | 2010 |
Assessing the pentose phosphate pathway using [2, 3‐13C2]glucose MH Lee, CR Malloy, IR Corbin, J Li, ES Jin NMR in Biomedicine 32 (6), e4096, 2019 | 31 | 2019 |
Doxorubicin-loaded hollow gold nanospheres for dual photothermal ablation and chemoembolization therapy RA Sheth, X Wen, J Li, MP Melancon, X Ji, Y Andrew Wang, CH Hsiao, ... Cancer nanotechnology 11, 1-16, 2020 | 26 | 2020 |
Enhanced antitumor efficacy of a vascular disrupting agent combined with an antiangiogenic in a rat liver tumor model evaluated by multiparametric MRI F Chen, Y Feng, K Zheng, F De Keyzer, J Li, Y Feng, MM Cona, H Wang, ... PLoS One 7 (7), e41140, 2012 | 24 | 2012 |
Radioiodinated hypericin: its biodistribution, necrosis avidity and therapeutic efficacy are influenced by formulation NY Cona MM, Alpizar YA, Li J, Bauwens M, Feng Y, Sun Pharmaceutical Research 31 (2), 278-90, 2014 | 22 | 2014 |
Small molecule sequential dual-targeting theragnostic strategy (SMSDTTS): from preclinical experiments towards possible clinical anticancer applications J Li, R Oyen, A Verbruggen, Y Ni Journal of Cancer 4 (2), 133, 2013 | 22 | 2013 |